港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

中慧生物-B

43.580

-1.800-3.97%

成交量：9.30万

成交额：407.83万

市值：171.46亿

市盈率：-55.66

高：45.380

开：45.380

低：43.000

收：45.380

52周最高：59.600

52周最低：33.000

股本：3.93亿

香港流通股本：2.96亿

量比：0.56

换手率：0.03%

股息：- -

股息率：- -

每股收益(LYR):-0.783

净资产收益率：--

总资产收益率：--

市净率：467.56

市盈率(LYR):-55.66

市销率: 48.61

数据加载中...

总览公司新闻公告

中慧生物-B(02627)申请H股全流通

中慧生物-B10月13日主力净流出35.6万元散户资金买入

中慧元通/怡道生物重组带状疱疹疫苗（CHO细胞）启动III期临床适应症为预防带状疱疹

中慧生物-B10月02日获主力加仓33万元

中慧生物-B09月30日获主力加仓50.8万元

中慧生物-B：2025中期报告

香港交易所

中慧生物-B09月23日主力净流出45.6万元散户资金买入

港股医药股反弹中慧生物涨超5%

南方财经网

中慧生物-B09月16日主力净流入142.2万元散户资金抛售

泰州父子卖电池，IPO了

科创最前线

港股异动 | 中慧生物-B(02627)涨超8% 四价流感病毒亚单位疫苗入选商保初步审查名单市场稀缺性显著

中慧生物-B09月15日主力净流出34.0万元散户资金买入

中慧生物-B09月12日主力净流入79.2万元散户资金抛售

中慧生物-B大跌5.07% 四价流感病毒亚单位疫苗上市申请获批

港股异动 | 中慧生物-B(02627.HK)涨超3% 四价流感病毒亚单位疫苗上市申请获国家药监局批准

智通港股早知道 | 美联储褐皮书显示就业水平总体保持稳定美联储9月降息概率为96.6%

中慧生物-B(02627)：四价流感病毒亚单位疫苗的上市申请获国家药监局批准

中慧生物-B四价亚单位流感疫苗获得中国国家药监局批准

中慧生物2025 年中期业绩报告：商业化加速兑现研发管线梯次突破

智通财经网

中慧生物(02627.HK)2025 年中期业绩报告：商业化加速兑现研发管线梯次突破

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02627/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02627","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"中慧生物-B","latestPrice":43.58,"timestamp":1760688489170,"preClose":45.38,"halted":0,"volume":93000,"delay":0,"floatShares":296361845,"shares":393442600,"eps":-0.7830104145824273,"marketStatus":"已收盘","change":-1.8,"latestTime":"10-17 16:08:09","open":45.38,"high":45.38,"low":43,"amount":4078300,"amplitude":0.052446,"askPrice":43.58,"askSize":200,"bidPrice":43.4,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.6792340643758156,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1760923800000},"marketStatusCode":5,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":45.38,"openAndCloseTimeList":[[1760664600000,1760673600000],[1760677200000,1760688000000]],"volumeRatio":0.560106,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","floatShares":296361845,"roa":"--","roe":"--","lyrEps":-0.78301,"volumeRatio":0.560106,"shares":393442600,"dividePrice":0,"high":45.38,"amplitude":0.052446,"preClose":45.38,"low":43,"week52Low":33,"pbRate":"467.56","psRate":"48.61","week52High":59.6,"institutionHeld":0,"latestPrice":43.58,"committee":0.666667,"eps":-0.7830104145824273,"divideRate":0,"volume":93000,"delay":0,"ttmEps":-0.6792340643758156,"open":45.38,"prevYearClose":12.9,"prevWeekClose":46.98,"prevMonthClose":49.3,"prevQuarterClose":49.3,"fiveDayClose":46.98,"twentyDayClose":51.55,"sixtyDayClose":12.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02627\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02627\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02627\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02627\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02627","date":"2025-10-16","current":-64.464379,"percent":0.382979,"low":-83.59026,"twenty":-77.931795,"median":-67.664342,"eighty":-62.20035,"high":-18.07815,"avg":-68.296822,"sd":11.369496,"marketCap":17854425188},"quantilePoints":[{"date":"2025-08-08","current":-18.07815,"twenty":-18.07815,"median":-18.07815,"eighty":-18.07815,"marketCap":5586884920},{"date":"2025-08-15","current":-60.155426,"twenty":-60.155426,"median":-56.438909,"eighty":-42.414982,"marketCap":18562621868},{"date":"2025-08-22","current":-65.870069,"twenty":-65.897052,"median":-63.746879,"eighty":-55.654938,"marketCap":20262293900},{"date":"2025-08-29","current":-64.920623,"twenty":-66.830053,"median":-65.395346,"eighty":-57.22288,"marketCap":20065572600},{"date":"2025-09-05","current":-62.716917,"twenty":-66.416243,"median":-63.912829,"eighty":-60.155426,"marketCap":19365244772},{"date":"2025-09-12","current":-62.655098,"twenty":-66.251138,"median":-63.08644,"eighty":-59.27469,"marketCap":19380982476},{"date":"2025-09-19","current":-81.048551,"twenty":-68.315951,"median":-63.912829,"eighty":-59.882299,"marketCap":19888523430},{"date":"2025-09-26","current":-77.095946,"twenty":-77.153546,"median":-65.395346,"eighty":-60.155426,"marketCap":18869507096},{"date":"2025-10-03","current":-76.784092,"twenty":-77.86406,"median":-66.074095,"eighty":-61.128611,"marketCap":18838031688},{"date":"2025-10-10","current":-75.450727,"twenty":-78.338288,"median":-66.623148,"eighty":-61.710077,"marketCap":18483933348},{"date":"2025-10-16","current":-72.937878,"twenty":-77.931795,"median":-67.664342,"eighty":-62.20035,"marketCap":17854425188}],"updateTime":1760673968204},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02627\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575977786","title":"中慧生物-B(02627)申请H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2575977786","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575977786?lang=zh_cn&edition=fundamental","pubTime":"2025-10-15 19:17","pubTimestamp":1760527078,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B(02627)发布公告，于2025年10月15日，公司已就将公司8166.2万股未上市股份转换为H股以及该等股份于联交所上市向中国证监会提交申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2575823742","title":"中慧生物-B10月13日主力净流出35.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2575823742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575823742?lang=zh_cn&edition=fundamental","pubTime":"2025-10-13 16:16","pubTimestamp":1760343365,"startTime":"0","endTime":"0","summary":"10月13日, 中慧生物-B股价跌4.47%，报收44.88元，成交金额440.4万元，换手率0.03%，振幅4.17%，量比0.57。中慧生物-B今日主力资金净流出35.6万元，上一交易日主力净流入27.5万元。该股近5个交易日下跌6.77%，主力资金累计净流入28.7万元；近20日主力资金累计净流入197.1万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013162316a45d4a03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013162316a45d4a03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2574465106","title":"中慧元通/怡道生物重组带状疱疹疫苗（CHO细胞）启动III期临床适应症为预防带状疱疹","url":"https://stock-news.laohu8.com/highlight/detail?id=2574465106","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574465106?lang=zh_cn&edition=fundamental","pubTime":"2025-10-11 18:30","pubTimestamp":1760178600,"startTime":"0","endTime":"0","summary":"江苏中慧元通生物科技有限公司与上海怡道生物科技有限公司联合研发的重组带状疱疹疫苗（CHO细胞）已启动Ⅲ期临床试验，登记号CTR20254023，首次公示日期为2025年10月11日。该疫苗为注射剂，用于40岁及以上成人预防带状疱疹，接种方式为上臂三角肌肌内注射，每次0.5mL，共接种2次，分别在第0月和第2月进行。试验主要目的是评价全程接种后36个月内预防带状疱疹的保护持久性，次要目的为评价36个月免疫持久性。主要终点指标为全程接种后36个月内带状疱疹确诊病例的人年发病率，次要终点指标包括抗-gE抗体阳性率、GMC。目前试验状态为进行中，目标入组7500人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101118443294c30be4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101118443294c30be4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["91190","BK1161","02627"],"gpt_icon":0},{"id":"2572427975","title":"中慧生物-B10月02日获主力加仓33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572427975","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572427975?lang=zh_cn&edition=fundamental","pubTime":"2025-10-02 16:15","pubTimestamp":1759392938,"startTime":"0","endTime":"0","summary":"10月02日, 中慧生物-B股价涨1.22%，报收49.90元，成交金额1285.1万元，换手率0.09%，振幅5.07%，量比1.21。中慧生物-B今日主力资金净流入33万元，连续3日净流入，上一交易日主力净流入50.8万元。该股近5个交易日上涨3.96%，主力资金累计净流入128.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入208.0万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100216183894b848aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100216183894b848aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2572302669","title":"中慧生物-B09月30日获主力加仓50.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572302669","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572302669?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 16:15","pubTimestamp":1759220140,"startTime":"0","endTime":"0","summary":"09月30日, 中慧生物-B股价涨5.88%，报收49.30元，成交金额1073.5万元，换手率0.07%，振幅6.57%，量比1.06。中慧生物-B今日主力资金净流入50.8万元，上一交易日主力净流入44.5万元。该股近5个交易日上涨1.78%，主力资金累计净流入95.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入138.2万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509301619419719f664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509301619419719f664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2571408319","title":"中慧生物-B：2025中期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2571408319","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571408319?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 16:57","pubTimestamp":1759136244,"startTime":"0","endTime":"0","summary":"中慧生物2025年上半年收入达7112.3万元，较去年同期的697.8万元大幅增长919%，主要受益于四价流感病毒亚单位疫苗销售增长。期内毛利6078.1万元，毛利率达85.5%。公司核心产品四价流感病毒亚单位疫苗已完成6-35月龄人群III期临床试验，并于2025年9月获国家药监局批准用于该年龄段人群。三价流感病毒亚单位疫苗的新药申请已于2024年9月获国家药监局受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092919005697b0c9db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092919005697b0c9db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2569799766","title":"中慧生物-B09月23日主力净流出45.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2569799766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569799766?lang=zh_cn&edition=fundamental","pubTime":"2025-09-23 16:15","pubTimestamp":1758615333,"startTime":"0","endTime":"0","summary":"09月23日, 中慧生物-B股价跌1.18%，报收48.44元，成交金额931.1万元，换手率0.07%，振幅4.04%，量比0.42。中慧生物-B今日主力资金净流出45.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌7.11%，主力资金累计净流出91.5万元；近20日主力资金累计净流入231.7万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923163830953fb377&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923163830953fb377&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2568045358","title":"港股医药股反弹 中慧生物涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568045358","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568045358?lang=zh_cn&edition=fundamental","pubTime":"2025-09-17 09:32","pubTimestamp":1758072736,"startTime":"0","endTime":"0","summary":"南方财经9月17日电，港股医药股反弹，截至发稿，中慧生物-B(02627.HK)涨5.47%、同源康医药-B(02410.HK)涨5.13%、荣昌生物(09995.HK)涨2.70%、药明巨诺-B(02126.HK)涨2.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509173515712278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","LU2328871848.SGD","02627","02126","BK1583","BK1161","02410","09995","LU1969619763.USD"],"gpt_icon":0},{"id":"2568434610","title":"中慧生物-B09月16日主力净流入142.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2568434610","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568434610?lang=zh_cn&edition=fundamental","pubTime":"2025-09-16 16:16","pubTimestamp":1758010569,"startTime":"0","endTime":"0","summary":"09月16日, 中慧生物-B股价涨9.38%，报收52.15元，成交金额5219.7万元，换手率0.34%，振幅13.46%，量比4.25。中慧生物-B今日主力资金净流入142.2万元，上一交易日主力净流出34.0万元。该股近5个交易日上涨11.96%，主力资金累计净流入151.4万元；近20日主力资金累计净流入785.9万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916162327a723e1bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916162327a723e1bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2568637434","title":"泰州父子卖电池，IPO了","url":"https://stock-news.laohu8.com/highlight/detail?id=2568637434","media":"科创最前线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568637434?lang=zh_cn&edition=fundamental","pubTime":"2025-09-16 15:20","pubTimestamp":1758007242,"startTime":"0","endTime":"0","summary":"无独有偶，同在今年8月，港交所也有一个泰州IPO备受瞩目。01泰州父子，收获一个IPO双登集团IPO的背后，一对“父子兵”的身影格外瞩目。为了挽回颓势，电池厂上级部门一连派出三任厂长，却都未果。如今，这对泰州父子终得偿所愿，收获一个IPO。但在储能电池领域，双登集团则具有领先市场地位。2024年公司锂离子和铅酸电池的收入占比分别为33.3%和64.6%，锂离子收入占比有所下降，主要是因为数据中心需求增加带动铅酸电池销量强劲增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509161524089530ea29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509161524089530ea29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1575","09698","BK1161","BK1613","BK1134","BK1588","BK1607","02627","BK1585"],"gpt_icon":0},{"id":"2567786151","title":"港股异动 | 中慧生物-B(02627)涨超8% 四价流感病毒亚单位疫苗入选商保初步审查名单 市场稀缺性显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2567786151","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567786151?lang=zh_cn&edition=fundamental","pubTime":"2025-09-16 11:34","pubTimestamp":1757993641,"startTime":"0","endTime":"0","summary":"智通财经APP在《国内首款全人群四价流感亚单位疫苗获批，中慧生物-B商业化放量在即》中指出，作为国内预防用生物制品一类新药，四价流感病毒亚单位疫苗已于今年8月进入商业保险创新药目录初步形式审查名单，且为名单中唯一入选的疫苗产品，稀缺性显著，预计上市后将有效填补相应市场空白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4614","HSCEI","BK1161","159646","YANG","02627"],"gpt_icon":1},{"id":"2567117301","title":"中慧生物-B09月15日主力净流出34.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2567117301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567117301?lang=zh_cn&edition=fundamental","pubTime":"2025-09-15 16:16","pubTimestamp":1757924165,"startTime":"0","endTime":"0","summary":"09月15日, 中慧生物-B股价跌3.21%，报收47.68元，成交金额954.4万元，换手率0.07%，振幅6.09%，量比0.86。中慧生物-B今日主力资金净流出34.0万元，上一交易日主力净流入79.2万元。该股近5个交易日下跌1.08%，主力资金累计净流入9.3万元；近20日主力资金累计净流入180.9万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915162331952e8319&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915162331952e8319&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2566897693","title":"中慧生物-B09月12日主力净流入79.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2566897693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566897693?lang=zh_cn&edition=fundamental","pubTime":"2025-09-12 16:15","pubTimestamp":1757664949,"startTime":"0","endTime":"0","summary":"09月12日, 中慧生物-B股价涨4.63%，报收49.26元，成交金额1102.9万元，换手率0.08%，振幅5.48%，量比1.00。中慧生物-B今日主力资金净流入79.2万元，上一交易日主力净流出0万元。该股近5个交易日下跌0.41%，主力资金累计净流出4.3万元；近20日主力资金累计净流入1535.1万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091216205695281c78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091216205695281c78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2566989224","title":"中慧生物-B大跌5.07% 四价流感病毒亚单位疫苗上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2566989224","media":"港美通","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566989224?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 10:18","pubTimestamp":1757470731,"startTime":"0","endTime":"0","summary":"消息面上，中慧生物-B近日宣布，中国国家药品监督管理局已批准集团针对6-35月龄人群的四价流感病毒亚单位疫苗的新药申请，该款疫苗为中国首款且唯一一款获批上市的全人群全剂量四价流感病毒亚单位疫苗。这一增长主要归因于四价流感病毒亚单位疫苗的销售逐步增加，以及对收入的调整以校准2024年销售的估计退货。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910102012a71afbf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910102012a71afbf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2564492703","title":"港股异动 | 中慧生物-B(02627.HK)涨超3% 四价流感病毒亚单位疫苗上市申请获国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2564492703","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564492703?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 10:00","pubTimestamp":1756951209,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159646","02627","BK1161"],"gpt_icon":0},{"id":"2564107443","title":"智通港股早知道 | 美联储褐皮书显示就业水平总体保持稳定 美联储9月降息概率为96.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564107443","media":"智通财经","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564107443?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 07:30","pubTimestamp":1756942247,"startTime":"0","endTime":"0","summary":"美联储褐皮书显示就业水平总体保持稳定 美联储9月降息概率为96.6%美联储褐皮书指出，十一个辖区报告就业水平总体保持稳定或几无净变化，一个辖区出现温和下降。据CME“美联储观察”：美联储9月维持利率不变的概率为3.4%，降息25个基点的概率为96.6%。该变更将于 2025 年 9 月 19 日星期五收盘后生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341267.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09863","ESmain","BK4588","YANG","BK4559","SDS","BK4614","BK1183","BK1613","BK4504","BK4581","02627","BK4585","BK1119","BK4534","HSTECH",".SPX","BK1161","SH","BK1152","SPXU","BK1536","SPY","09880","OEX","OEF","SSO","00315","MESmain","BK4550","UPRO","IVV","HSCEI"],"gpt_icon":1},{"id":"2564308361","title":"中慧生物-B(02627)：四价流感病毒亚单位疫苗的上市申请获国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2564308361","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564308361?lang=zh_cn&edition=fundamental","pubTime":"2025-09-03 17:36","pubTimestamp":1756892194,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，公司董事会欣然宣布，中国国家药品监督管理局已批准集团针对6-35月龄人群的四价流感病毒亚单位疫苗的新药申请。截至本公告日期，该款疫苗成为中国首款且唯一一款获批上市的全人群全剂量四价流感病毒亚单位疫苗。集团的产品包括但不限于，四价流感病毒亚单位疫苗及在研冻干人用狂犬病疫苗，以及其他在研疫苗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627","159646","BK1161"],"gpt_icon":0},{"id":"1135028630","title":"中慧生物-B四价亚单位流感疫苗获得中国国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1135028630","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135028630?lang=zh_cn&edition=fundamental","pubTime":"2025-09-03 17:35","pubTimestamp":1756892115,"startTime":"0","endTime":"0","summary":"中慧生物-B的四价亚单位流感疫苗申请获得中国国家药品监督管理局批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2563243000","title":"中慧生物2025 年中期业绩报告：商业化加速兑现 研发管线梯次突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2563243000","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563243000?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 12:51","pubTimestamp":1756443067,"startTime":"0","endTime":"0","summary":"财报显示，公司核心产品四价流感病毒亚单位疫苗——慧尔康欣 商业化成效显著，营收实现跨越式增长，期内亏损同比收窄，同时研发管线按计划推进，全球化布局逐步落地。数据显示，中慧生物上半年经营业绩呈现显著向好趋势。目前已完成I期临床并显示良好安全性特征。2024 年已获澳门注册证书，菲律宾注册程序顺利启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829125346a7031050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829125346a7031050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2563018889","title":"中慧生物(02627.HK)2025 年中期业绩报告：商业化加速兑现 研发管线梯次突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2563018889","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563018889?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 12:43","pubTimestamp":1756442584,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159837","BK1161","02627","159646"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":115,"code":"91000000","status":"200"}]}}